 | • レポートコード：QYR9N7839 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・プレリキサフォルの世界市場規模 ・主要企業別市場シェア ・プレリキサフォルの世界市場規模：種類別（24MG / 1.2ML、タイプII） ・プレリキサフォルの世界市場規模：用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者） ・プレリキサフォルのアメリカ市場規模（種類別、用途別） ・プレリキサフォルのヨーロッパ市場規模（種類別、用途別） ・プレリキサフォルの中国市場規模（種類別、用途別） ・プレリキサフォルの日本市場規模（種類別、用途別） ・プレリキサフォルの東南アジア市場規模（種類別、用途別） ・プレリキサフォルのインド市場規模（種類別、用途別） ・プレリキサフォルの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・プレリキサフォルの世界市場予測（2019年-2025年） ・プレリキサフォルの地域別市場予測（2019年-2025年） ... |
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.In 2018, the global Plerixafor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Plerixafor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plerixafor development in United States, Europe and China.
The key players covered in this study
sanofi-aventis
…
Market segment by Type, the product can be split into
24MG/1.2ML
Type II
Market segment by Application, split into
Non-Hodgkin’s lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Plerixafor status, future forecast, growth opportunity, key market and key players.
To present the Plerixafor development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Plerixafor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Plerixafor Market Size Growth Rate by Type (2014-2025)
1.4.2 24MG/1.2ML
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Plerixafor Market Share by Application (2014-2025)
1.5.2 Non-Hodgkin’s lymphoma (NHL) Patients
1.5.3 Multiple myeloma (MM) Patients
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Plerixafor Market Size
2.2 Plerixafor Growth Trends by Regions
2.2.1 Plerixafor Market Size by Regions (2014-2025)
2.2.2 Plerixafor Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Plerixafor Market Size by Manufacturers
3.1.1 Global Plerixafor Revenue by Manufacturers (2014-2019)
3.1.2 Global Plerixafor Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Plerixafor Market Concentration Ratio (CR5 and HHI)
3.2 Plerixafor Key Players Head office and Area Served
3.3 Key Players Plerixafor Product/Solution/Service
3.4 Date of Enter into Plerixafor Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Plerixafor Market Size by Type (2014-2019)
4.2 Global Plerixafor Market Size by Application (2014-2019)
5 United States
5.1 United States Plerixafor Market Size (2014-2019)
5.2 Plerixafor Key Players in United States
5.3 United States Plerixafor Market Size by Type
5.4 United States Plerixafor Market Size by Application
6 Europe
6.1 Europe Plerixafor Market Size (2014-2019)
6.2 Plerixafor Key Players in Europe
6.3 Europe Plerixafor Market Size by Type
6.4 Europe Plerixafor Market Size by Application
7 China
7.1 China Plerixafor Market Size (2014-2019)
7.2 Plerixafor Key Players in China
7.3 China Plerixafor Market Size by Type
7.4 China Plerixafor Market Size by Application
8 Japan
8.1 Japan Plerixafor Market Size (2014-2019)
8.2 Plerixafor Key Players in Japan
8.3 Japan Plerixafor Market Size by Type
8.4 Japan Plerixafor Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Plerixafor Market Size (2014-2019)
9.2 Plerixafor Key Players in Southeast Asia
9.3 Southeast Asia Plerixafor Market Size by Type
9.4 Southeast Asia Plerixafor Market Size by Application
10 India
10.1 India Plerixafor Market Size (2014-2019)
10.2 Plerixafor Key Players in India
10.3 India Plerixafor Market Size by Type
10.4 India Plerixafor Market Size by Application
11 Central & South America
11.1 Central & South America Plerixafor Market Size (2014-2019)
11.2 Plerixafor Key Players in Central & South America
11.3 Central & South America Plerixafor Market Size by Type
11.4 Central & South America Plerixafor Market Size by Application
12 International Players Profiles
12.1 sanofi-aventis
12.1.1 sanofi-aventis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Plerixafor Introduction
12.1.4 sanofi-aventis Revenue in Plerixafor Business (2014-2019)
12.1.5 sanofi-aventis Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Plerixafor Key Market Segments
Table Key Players Plerixafor Covered
Table Global Plerixafor Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Plerixafor Market Size Market Share by Type 2014-2025
Figure 24MG/1.2ML Figures
Table Key Players of 24MG/1.2ML
Figure Type II Figures
Table Key Players of Type II
Table Global Plerixafor Market Size Growth by Application 2014-2025 (Million US$)
Figure Non-Hodgkin's lymphoma (NHL) Patients Case Studies
Figure Multiple myeloma (MM) Patients Case Studies
Figure Plerixafor Report Years Considered
Table Global Plerixafor Market Size 2014-2025 (Million US$)
Figure Global Plerixafor Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Plerixafor Market Size by Regions 2014-2025 (Million US$)
Table Global Plerixafor Market Size by Regions 2014-2019 (Million US$)
Table Global Plerixafor Market Share by Regions 2014-2019
Figure Global Plerixafor Market Share by Regions 2014-2019
Figure Global Plerixafor Market Share by Regions 2019
Table Market Top Trends
Table Global Plerixafor Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Plerixafor Market Share by Manufacturers (2014-2019)
Figure Global Plerixafor Market Share by Manufacturers in 2018
Table Global Plerixafor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Plerixafor Product/Solution/Service
Table Date of Enter into Plerixafor Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Plerixafor Market Size by Type (2014-2019) (Million US$)
Table Global Plerixafor Market Size Share by Type (2014-2019)
Figure Global Plerixafor Market Size Market Share by Type (2014-2019)
Table Global Plerixafor Market Size by Application (2014-2019) (Million US$)
Table Global Plerixafor Market Size Share by Application (2014-2019)
Figure Global Plerixafor Market Size Market Share by Application (2014-2019)
Figure Global Plerixafor Revenue Market Share by Application in 2018
Figure United States Plerixafor Market Size 2014-2019 (Million US$)
Table United States Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table United States Key Players Plerixafor Market Share (2018-2019)
Table United States Plerixafor Market Size by Type (2014-2019) (Million US$)
Table United States Plerixafor Market Share by Type (2014-2019)
Table United States Plerixafor Market Size by Application (2014-2019) (Million US$)
Table United States Plerixafor Market Share by Application (2014-2019)
Figure Europe Plerixafor Market Size 2014-2019 (Million US$)
Table Europe Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table Europe Key Players Plerixafor Market Share (2018-2019)
Table Europe Plerixafor Market Size by Type (2014-2019) (Million US$)
Table Europe Plerixafor Market Share by Type (2014-2019)
Table Europe Plerixafor Market Size by Application (2014-2019) (Million US$)
Table Europe Plerixafor Market Share by Application (2014-2019)
Figure China Plerixafor Market Size 2014-2019 (Million US$)
Table China Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table China Key Players Plerixafor Market Share (2018-2019)
Table China Plerixafor Market Size by Type (2014-20189) (Million US$)
Table China Plerixafor Market Share by Type (2014-2019)
Table China Plerixafor Market Size by Application (2014-2019) (Million US$)
Table China Plerixafor Market Share by Application (2014-2019)
Figure Japan Plerixafor Market Size 2014-2019 (Million US$)
Table Japan Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table Japan Key Players Plerixafor Market Share (2018-2019)
Table Japan Plerixafor Market Size by Type (2014-2019) (Million US$)
Table Japan Plerixafor Market Share by Type (2014-2019)
Table Japan Plerixafor Market Size by Application (2014-2019) (Million US$)
Table Japan Plerixafor Market Share by Application (2014-2019)
Figure Southeast Asia Plerixafor Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Plerixafor Market Share (2018-2019)
Table Southeast Asia Plerixafor Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Plerixafor Market Share by Type (2014-2019)
Table Southeast Asia Plerixafor Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Plerixafor Market Share by Application (2014-2019)
Figure India Plerixafor Market Size 2014-2019 (Million US$)
Table India Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table India Key Players Plerixafor Market Share (2018-2019)
Table India Plerixafor Market Size by Type (2014-2019) (Million US$)
Table India Plerixafor Market Share by Type (2014-2019)
Table India Plerixafor Market Size by Application (2014-2019) (Million US$)
Table India Plerixafor Market Share by Application (2014-2019)
Figure Central & South America Plerixafor Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Plerixafor Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Plerixafor Market Share (2018-2019)
Table Central & South America Plerixafor Market Size by Type (2014-2019) (Million US$)
Table Central & South America Plerixafor Market Share by Type (2014-2019)
Table Central & South America Plerixafor Market Size by Application (2014-2019) (Million US$)
Table Central & South America Plerixafor Market Share by Application (2014-2019)
Table sanofi-aventis Company Details
Table sanofi-aventis Revenue in Plerixafor Business (2014-2019) (Million US$)
Figure sanofi-aventis Revenue Growth Rate in Plerixafor Business (2014-2019)
Table sanofi-aventis Recent Development
Table Global Plerixafor Market Size by Regions (Million US$) 2019-2025
Figure Global Plerixafor Market Size Share by Regions (2019-2025)
Figure Global Plerixafor Market Size Share by Regions in 2025
Figure United States Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure Europe Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure China Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure Japan Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure India Plerixafor Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Plerixafor Market Size Forecast (2019-2025)(Million USD)
Table Global Plerixafor Market Size by Product (2019-2025) (Million US$)
Figure Global Plerixafor Market Size by Product (2019-2025)
Figure Global Plerixafor Market Size by Product in 2025
Table Global Plerixafor Market Size by Application (2019-2025) (Million US$)
Figure Global Plerixafor Market Size by Application (2019-2025)
Figure Global Plerixafor Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の多発性骨髄腫の治療市場：市場規模・現状・予測 Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…- 世界の悪性リンパ腫市場：市場規模・現状・予測 Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…
- 世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 世界のロミプロスチム市場：市場規模・現状・予測 Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.In 2018, the global Romiplostim market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses o…
- 世界のエトラビリン市場：市場規模・現状・予測 Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…